This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kuroda, M. Articles by Watanabe, T. Search for Related Content PubMed PubMed Citation Articles by Kuroda, M. Articles by Watanabe, T.

American Journal of Pathology, Vol 151, 735-744, Copyright © 1997 by American Society for Investigative Pathology

REGULAR ARTICLES

Oncogenic transformation and inhibition of adipocytic conversion of preadipocytes by TLS/FUS-CHOP type II chimeric protein

M Kuroda, T Ishida, M Takanashi, M Satoh, R Machinami and T Watanabe
Department of Pathology, University of Tokyo, Japan.

Myxoid liposarcomas are characterized by t(12; 16)(q13;p11) translocation and expression of TLS/ FUS-CHOP chimeric transcripts (types I to III). Among these, the type II transcript is expressed in the majority of cases of myxoid and round cell liposarcoma. To investigate the function of the type II chimeric protein, we obtained stable transformants of ST-13, a murine preadipocytic cell line, which express TLS/FUS-CHOP type II protein (ST-TC) or CHOP protein (ST-C) as well as vector-transfected controls (ST-V). ST-TC and ST-C cells showed almost complete or partial resistance to adipogenic conversion by insulin and thiazolidinedione, respectively. Induction by adipogenic stimulation of the adipocytic genes such as C/EBP alpha, aP2, and adipsin was almost totally suppressed in the ST-TC cells, whereas in ST- C cells C/EBP alpha alone was induced without induction of aP2 and adipsin. Transcriptional suppression of the C/EBP alpha gene in ST-TC cells was suggested by the results of chloramphenicol acetyltransferase (CAT) assay showing a significantly lower C/EBP alpha promoter activity compared with findings in ST-C and ST-V cells. Failure to rescue adipogenic conversion by ectopic expression of C/EBP alpha in ST-TC cells suggested a functional impairment of C/EBP alpha to induce expression of downstream genes. TLS/FUS-CHOP type II protein showed transforming activity, as evidenced by loss of contact inhibition of growth, anchorage-independent growth in soft agar, and tumor formation in nude mice, showing typical histological features of myxoid liposarcoma seen in humans. These findings suggest important roles for TLS/FUS-CHOP type II protein in the oncogenesis of myxoid liposarcoma.

This article has been cited by other articles:

				P. A. Perez-Mancera, C. Vicente-Duenas, I. Gonzalez-Herrero, M. Sanchez-Martin, T. Flores-Corral, and I. Sanchez-Garcia Fat-specific FUS-DDIT3-transgenic mice establish PPAR{gamma} inactivation is required to liposarcoma development Carcinogenesis, October 1, 2007; 28(10): 2069 - 2073. [Abstract] [Full Text] [PDF]

				N. Riggi, L. Cironi, P. Provero, M.-L. Suva, J.-C. Stehle, K. Baumer, L. Guillou, and I. Stamenkovic Expression of the FUS-CHOP Fusion Protein in Primary Mesenchymal Progenitor Cells Gives Rise to a Model of Myxoid Liposarcoma. Cancer Res., July 15, 2006; 66(14): 7016 - 7023. [Abstract] [Full Text] [PDF]

				K. Engstrom, H. Willen, C. Kabjorn-Gustafsson, C. Andersson, M. Olsson, M. Goransson, S. Jarnum, A. Olofsson, E. Warnhammar, and P. Aman The Myxoid/Round Cell Liposarcoma Fusion Oncogene FUS-DDIT3 and the Normal DDIT3 Induce a Liposarcoma Phenotype in Transfected Human Fibrosarcoma Cells Am. J. Pathol., May 1, 2006; 168(5): 1642 - 1653. [Abstract] [Full Text] [PDF]

				M. Kuroda, H. Tanabe, K. Yoshida, K. Oikawa, A. Saito, T. Kiyuna, H. Mizusawa, and K. Mukai Alteration of chromosome positioning during adipocyte differentiation J. Cell Sci., November 15, 2004; 117(24): 5897 - 5903. [Abstract] [Full Text] [PDF]

				K. Oikawa, T. Ohbayashi, T. Kiyono, H. Nishi, K. Isaka, A. Umezawa, M. Kuroda, and K. Mukai Expression of a Novel Human Gene, Human Wings Apart-Like (hWAPL), Is Associated with Cervical Carcinogenesis and Tumor Progression Cancer Res., May 15, 2004; 64(10): 3545 - 3549. [Abstract] [Full Text] [PDF]

				Y. Yajima, M. Sato, M. Sumida, and S. Kawashima Mechanism of Adult Primitive Mesenchymal ST-13 Preadipocyte Differentiation Endocrinology, June 1, 2003; 144(6): 2559 - 2565. [Abstract] [Full Text] [PDF]

				C. R. Antonescu, A. Elahi, M. Humphrey, M. Y. Lui, J. H. Healey, M. F. Brennan, J. M. Woodruff, S. C. Jhanwar, and M. Ladanyi Specificity of TLS-CHOP Rearrangement for Classic Myxoid/Round Cell Liposarcoma: Absence in Predominantly Myxoid Well-Differentiated Liposarcomas J. Mol. Diagn., August 1, 2000; 2(3): 132 - 138. [Abstract] [Full Text]

				C. R. Antonescu, A. Elahi, J. H. Healey, M. F. Brennan, M. Y. Lui, J. Lewis, S. C. Jhanwar, J. M. Woodruff, and M. Ladanyi Monoclonality of Multifocal Myxoid Liposarcoma: Confirmation by Analysis of TLS-CHOP or EWS-CHOP Rearrangements Clin. Cancer Res., July 1, 2000; 6(7): 2788 - 2793. [Abstract] [Full Text]

				R. Horie, V. Gattei, K. Ito, S. Imajo-Ohmi, T. Tange, J. Miyauchi, A. Pinto, M. Degan, A. De Iuliis, F. Tassan Mazzocco, et al. Frequent Expression of the Variant CD30 in Human Malignant Myeloid and Lymphoid Neoplasms Am. J. Pathol., December 1, 1999; 155(6): 2029 - 2041. [Abstract] [Full Text] [PDF]

				M. Kuroda, X. Wang, J. Sok, Y. Yin, P. Chung, J. W. Giannotti, K. A. Jacobs, L. J. Fitz, P. Murtha-Riel, K. J. Turner, et al. Induction of a secreted protein by the myxoid liposarcoma oncogene PNAS, April 27, 1999; 96(9): 5025 - 5030. [Abstract] [Full Text] [PDF]

				J. KIM and J. PELLETIER Molecular genetics of chromosome translocations involving EWS and related family members Physiol Genomics, November 11, 1999; 1(3): 127 - 138. [Abstract] [Full Text] [PDF]